Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
2021 · Science Immunology · 617 citations
https://doi.org/10.1126/sciimmunol.abl4340
A
Alexandre Gaudet
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
61
Papers
2.3K
Citations
17
h-index
20
i10-index
Alexandre Gaudet is an academic researcher from Université de Lille. The author has contributed to research in topics: Inflammation biomarkers and pathways & Respiratory Support and Mechanisms & COVID-19 Clinical Research Studies. The author has an h-index of 17, co-authored 52 publications.
ORCID: 0000-0003-3787-8135Papers by this author
worksOutcomes After Endovascular Therapy With Procedural Sedation vs General Anesthesia in Patients With Acute Ischemic Stroke
2023 · JAMA Neurology · 126 citations
https://doi.org/10.1001/jamaneurol.2023.0413
Prone positioning during venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a pooled individual patient data analysis
2022 · Critical Care · 55 citations
https://doi.org/10.1186/s13054-021-03879-w
Impact of acute renal failure on plasmatic levels of cleaved endocan
2019 · Critical Care · 7 citations
https://doi.org/10.1186/s13054-019-2349-1
Alteplase in COVID-19 severe hypoxemic respiratory failure: the TRISTARDS multicenter randomized trial
2024 · Annals of Intensive Care · 3 citations
https://doi.org/10.1186/s13613-024-01386-z
Vascular leakage during circulatory failure: physiopathology, impact and treatments
2025 · Annals of Intensive Care · 3 citations
https://doi.org/10.1186/s13613-025-01474-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat